Welminic ls, welminic ls junior
Each ml contains: levosalbutamol sulphate ip eq. To levosalbutamol 0.25mg ambroxol hydrochloride ip 7.5mg guaiphemesin ip 12.5mg in a flavoured syrupy base q.s.
15 ml
The drug combination of levosalbutamol, ambroxol, and guaifenesin is used to treat coughs associated with mucus, particularly in conditions like bronchitis, asthma, and copd. Levosalbutamol is a bronchodilator that relaxes and widens airways, ambroxol is a mucolytic that thins and loosens mucus, and guaifenesin is an expectorant that decreases mucus stickiness to help with clearance.
The duration of action for the combination of levosalbutamol, ambroxol, and guaiphenesin is primarily determined by levosalbutamol, which is a short-acting bronchodilator providing relief for approximately 4 to 6 hours
Levosalbutamol ambroxol guaiphensin should be used exactly as prescribed by a healthcare professional, with the dose measured using a provided measuring cup or oral syringe
Tremors or nervousness (from levosalbutamol),mild palpitations or increased heart rate,dry mouth or throat irritation,nausea, vomiting, or stomach discomfort
The combination of levosalbutamol, ambroxol, and guaifenesin provides a multi-pronged approach to treating productive cough and associated respiratory conditions by acting as a bronchodilator, a mucolytic, and an expectorant.
No
No
